American Society of Echocardiography Recommendations for Performance, Interpretation, and Application of Stress Echocardiography

Journal of the American Society of Echocardiography

Volumn 20, Issue 9, 2007, Pages 1021-1041

  Pellikka, Patricia A ^a   Nagueh, Sherif F ^b   Elhendy, Abdou A ^c   Kuehl, Cathryn A ^a   Sawada, Stephen G ^d  

^a MAYO CLINIC   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c MARSHFIELD CLINIC   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMINOPHYLLINE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE;

BICYCLE; BRADYCARDIA; CONTINUOUS INFUSION; CORONARY ARTERY DISEASE; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; EQUIPMENT; HEART ATRIUM PACING; HEART MUSCLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; IMAGING AND DISPLAY; MEDICAL SOCIETY; METHODOLOGY; PHARMACOLOGIC STRESS TESTING; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; REVIEW; STRESS ECHOCARDIOGRAPHY; SUPINE POSITION; TREADMILL; VALVULAR HEART DISEASE; VASODILATATION;

CARDIAC PACING, ARTIFICIAL; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 34548251036     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2007.07.003     Document Type: Review

References (214)

1. Armstrong W., Pellikka P., Ryan T., Crouse L., Zoghbi W., and Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. J Am Soc Echocardiogr 11 (1998) 97-104
2. Feigenbaum H. Digital recording, display, and storage of echocardiograms. J Am Soc Echocardiogr 1 (1988) 378-383
3. Skolnick D., Sawada S., Feigenbaum H., and Segar D. Enhanced endocardial visualization with noncontrast harmonic imaging during stress echocardiography. J Am Soc Echocardiogr 12 (1999) 559-563
4. Franke A., Hoffman R., and Kuhl H. Non-contrast second harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality. Heart 83 (2000) 133-140
5. Sozi F., Poldermans D., and Bax J. Second harmonic imaging improves sensitivity of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am Heart J 142 (2001) 153-159
6. Rainbird A., Mulvagh S., Oh J., McCully R., Klarich K., Shub C., et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 14 (2001) 378-385
7. Vlassak I., Rubin D., and Odabashian J. Contrast and harmonic imaging improves the accuracy and efficiency of novice readers for dobutamine stress echocardiography. Echocardiography 19 (2002) 483-488
8. Dolan M., Riad K., and El-Shafei A. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 142 (2001) 908-915
9. Thanigaraji S., Nease R., Schechtman K., Wade R., Loslo S., and Perez J. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 87 (2001) 1430-1432
10. Castello R., Bella J., Rovner A., Swan J., Smith J., and Shaw J. Efficacy and time-efficiency of "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J 145 (2003) 535-541
11. Bruce R., Kusumi F., and Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85 (1973) 546-562
12. Roger V., Pellikka P., Oh J., Miller F.J., Seward J., and Tajik A. Stress echocardiography, part I: exercise echocardiography; techniques, implementation, clinical applications, and correlations. [see comments]. Mayo Clin Proc 70 (1995) 5-15
13. Grunig E., Janssen B., Mereles D., Barth U., Borst M., Vogt I., et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 102 (2000) 1145-1150
14. Modesto K., Rainbird A., Klarich K., Mahoney D., Chandrasekaran K., and Pellikka P. Comparison of supine bicycle exercise and treadmill exercise Doppler echocardiography in evaluation of patients with coronary artery disease. Am J Cardiol 91 (2003) 1245-1248
15. Sawada S., Segar D., Ryan T., Brown S., Dohan A., Williams R., et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 83 (1991) 1605-1614
16. Mathias Jr. W., Arruda A., Santos F., Arruda A., Mattos E., Osorio A., et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 12 (1999) 785-791
17. Ling L., Pellikka P., Mahoney D., Oh J., McCully R., Roger V., et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 28 (1996) 551-557
18. Lewandowski T., Armstrong W., and Bach D. Reduced test time by early identification of patients requiring atropine during dobutamine stress echocardiography. J Am Soc Echocardiogr 11 (1998) 236-243
19. Burger A., Notarianni M., and Aronson D. Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease. Am J Cardiol 86 (2000) 825-829
20. Pellikka P., Roger V., Oh J., Miller Jr. F., Seward J., and Tajik A. Stress echocardiography, part II: dobutamine stress echocardiography; techniques, implementation, clinical applications, and correlations. [see comments]. Mayo Clin Proc 70 (1995) 16-27
21. Karagiannis S., Bax J., Elhendy A., Feringa H., Cookinos D., van Domburg R., et al. Enhanced sensitivity of dobutamine stress echocardiography by observing wall motion abnormalities during the recovery phase after acute beta blocker administration. Am J Cardiol 97 (2006) 462-465
22. Chaowalit N., McCully R., Callahan M., Mookadam F., Bailey K., and Pellikka P. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. Eur Heart J 27 (2006) 3039-3044
23. Cornel J., Balk A., Boersma E., Maat A., Elhendy A., Arnese M., et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 9 (1996) 27-32
24. Pellikka P., Roger V., Oh J., Seward J., and Tajik A. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm >4 cm in diameter. Am J Cardiol 77 (1996) 413-416
25. Takhtehchian D., Novaro G., Barnett G., Griffin B., and Pellikka P. Safety of dobutamine stress echocardiography in patients with unruptured intracranial aneurysms. J Am Soc Echocardiogr 15 (2002) 1401-1404
26. Elhendy A., Windle J., and Porter T. Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators. Am J Cardiol 92 (2003) 475-477
27. Bremer M., Monahan K., Stussy V., Miller Jr. F., Seward J., and Pellikka P. Safety of dobutamine stress echocardiography supervised by registered nurse sonographers. J Am Soc Echocardiogr 11 (1998) 601-605
28. Picano E., and Lattanzi F. Dipyridamole echocardiography: a new diagnostic window on coronary artery disease. Circulation 83 (1991) III19-III26
29. Picano E., Marini C., Pirelli S., Maffei S., Bolognese L., Chiriatti G., et al. Safety of intravenous high-dose dipyridamole echocardiography: the echo-Persantine international cooperative study group. Am J Cardiol 70 (1992) 252-258
30. Picano E., Alaimo A., Chubuchny V., Polonska E., Baldo V., Baldini U., et al. Noninvasive pacemaker stress echocardiography for diagnosis of coronary artery disease: a multicenter study. J Am Coll Cardiol 40 (2002) 1305-1310
31. Biagini E., Schinkel A., Elhendy A., Bax J., Rizzello V., van Domburg R., et al. Pacemaker stress echocardiography predicts cardiac events in patients with permanent pacemaker. Am J Med 118 (2005) 1381-1386
32. Lee C., Pellikka P., McCully R., Mahoney D., and Seward J. Non exercise stress transthoracic echocardiography: transesophageal atrial pacing versus dobutamine stress. J Am Coll Cardiol 33 (1999) 506-511
33. Rainbird A., Pellikka P., Stussy V., Mahoney D., and Seward J. A rapid stress-testing protocol for the detection of coronary artery disease: comparison of two-stage transesophageal atrial pacing stress echocardiography with dobutamine stress echocardiography. J Am Coll Cardiol 36 (2000) 1659-1663
34. Quinones M., Douglas P., Foster E., Gorcsan J., Lewis J., Pearlman A., et al. ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine task force on clinical competence. J Am Coll Cardiol 41 (2003) 687-708
35. Bierig S., Ehler D., Knoll M., and Waggoner A. American Society of Echocardiography minimum standards for the cardiac sonographer: a position paper. J Am Soc Echocardiogr 19 (2006) 471-474
36. Lang R., Bierig M., Devereux R., Flachskampf F., Foster E., Pellikka P., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
37. Senior R., and Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 26 (1995) 26-32
38. Tyberg J., Parmley W., and Sonnenblick E. In-vitro studies of myocardial asynchrony and regional hypoxia. Circ Res 25 (1969) 569-579
39. Pislaru C., Belohlavek M., Bae R., Abraham T., Greenleaf F., and Seward J. Regional asynchrony during acute myocardial ischemia quantified by ultrasound strain rate imaging. J Am Coll Cardiol 37 (2001) 1141-1148
40. Sutherland G., Kukulski T., Kvitting J., D'hooge J., Arnold M., and Brandt E. Quantitation of left-ventricular asynergy by cardiac ultrasound. Am J Cardiol 86 (2000) 4-9G
41. Kvitting J., Wigstrom L., Strotmann J., and Sutherland G. How accurate is visual assessment of synchronicity in myocardial motion?. An in vitro study with computer simulated regional delay in myocardial motion: clinical implications for rest and stress echocardiography studies. J Am Soc Echocardiogr 12 (1999) 698-705
42. Hoffmann R., Marwick T., Poldermans D., Lethen H., Ciani R., and van der Meer P. Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J 23 (2002) 821-829
43. Johnson L., Ellis K., Schmidt D., Weiss M., and Cannon P. Volume ejected in early systole: a sensitive index of left ventricular performance in coronary artery disease. Circulation 52 (1975) 1075-1083
44. Holman B., Wynne J., Idoine J., and Neill J. Disruption in the temporal sequence of regional ventricular contraction, I: characteristics and incidence in coronary artery disease. Circulation 61 (1980) 1075-1083
45. Arsenault M., Crete M., and Bergeron S. Left ventricular shape assessment: a new simple diagnostic tool in stress echocardiography. J Am Soc Echocardiogr 15 (2002) 1321-1325
46. Attenhofer C., Pellikka P., Oh J., Roger V., Sohn D., and Seward J. Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease. J Am Coll Cardiol 27 (1996) 1171-1177
47. Roman S., Vilacosta J., Rollan M., Castillo J., Alonso J., Duran J., et al. Right ventricular asynergy during dobutamine-atropine echocardiography. J Am Coll Cardiol 30 (1997) 430-435
48. O'Sullivan C., Duncan A., Daly C., Li W., Oldershaw P., and Henein M. Dobutamine stress-induced ischemic right ventricular dysfunction and its relation to cardiac output in patients with three-vessel coronary artery disease with angina-like symptoms. Am J Cardiol 62 (2005) 622-627
49. Carstensen S., Ali S., Stensgaard-Hansen F., Toft J., Haunso S., and Kelbaek H. Dobutamine-atropine stress echocardiography in asymptomatic healthy individuals: the relativity of stress-induced hyperkinesia. Circulation 92 (1995) 3453-3463
50. Coletta C., Galati A., Ricci R., Sestili A., Guagnozzi G., Re F., et al. Prognostic value of left ventricular volume response during dobutamine stress echocardiography. Eur Heart J 18 (1997) 1599-1605
51. Olson C., Porter T., Deligonul U., Xie F., and Anderson J. Prognostic value of left ventricular volume response during dobutamine stress echocardiography. J Am Coll Cardiol 24 (1994) 1268-1273
52. Anselmi M., Golia G., Marino P., Vitolo A., Rossi A., Caraffi G., et al. Comparison of left ventricular function and volumes during transesophageal atrial pacing combined with two dimensional echocardiography in patients with syndrome X, atherosclerotic coronary artery disease, and normal subjects. Am J Cardiol 80 (1997) 1261-1265
53. Labovitz A., Pearson A., and Chaitman B. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am J Cardiol 62 (1988) 1180-1185
54. Sochor H., Pachinger O., Ogris E., Probst P., and Kaindl F. Radionuclide imaging after coronary vasodilation: myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole. Eur Heart J 5 (1984) 500-509
55. Klein H., Ninio R., Eliyahu S., Bakst A., Levi A., and Dean H. Effects of the dipyridamole test on left ventricular function in coronary artery disease. Am J Cardiol 69 (1992) 482-488
56. Ginzton L., Conant R., Brizendine M., Lee F., Mena I., and Laks M. Exercise subcostal two-dimensional echocardiography: a new method of segmental wall motion analysis. Am J Cardiol 53 (1984) 805-811
57. Freeman M., Berman D., Staniloff H., Elkayam U., Maddahi J., and Swan H. Comparison of upright and supine bicycle exercise in the detection and evaluation of extent of coronary artery disease by equilibrium radionuclide ventriculography. Am Heart J 102 (1981) 182-189
58. Zwehl W., Gueret P., Meerbaum S., Holt D., and Corday E. Quantitative two dimensional echocardiography during bicycle exercise in normal subjects. Am J Cardiol 47 (1981) 866-873
59. Poliner L., Dehmer G., Lewis S., Parkey R., Blomqvist C., and Willerson J. Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions. Circulation 62 (1980) 528-534
60. Poldermans D., Arnese M., Fioretti P., Salustri A., Boersma E., Thomson I., et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 26 (1995) 648-653
61. Das M., Pellikka P., Mahoney D., Roger V., Oh J., McCully R., et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 35 (2000) 1647-1653
62. Panza J., Curiel R., Laurienzo J., Quyyumi A., and Dilsizian V. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with coronary artery disease. Circulation 92 (1995) 2095-2101
63. Hoffmann R., Lethen H., Marwick T., Arnese M., Fioretti P., Pingitore A., et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 27 (1996) 330-336
64. Anand D., Theodosiadis I., and Senior R. Improved interpretation of dobutamine stress echocardiography following 4 months of systematic training in patients following acute myocardial infarction. Eur J Echocardiogr 5 (2004) 12-17
65. Chuah S., Pellikka P., Roger V., McCully R., and Seward J. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 97 (1998) 1474-1480
66. Lang R., Vignon P., Weinert L., Bednarz J., Korcarz C., Sandelski J., et al. Echocardiographic quantification of regional left ventricular wall motion with color kinesis. Circulation 93 (1996) 1877-1885
67. Mor-Avi V., Vignon P., and Koch R. Segmental analysis of color kinesis images: new method for quantification of the magnitude and timing of endocardial motion during left ventricular systole and diastole. Circulation 95 (1997) 2082-2097
68. Cain P., Baglin T., Case C., Spicer D., Short L., and Marwick T. Application of tissue Doppler to interpretation of dobutamine echocardiography and comparison with quantitative coronary angiography. Am Coll Cardiol 87 (2001) 525-531
69. Madler C., Payne N., and Wilkenshoff U. Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 24 (2003) 1587-1594
70. Fathi R., Cain P., Nakatani S., Yu H., and Marwick T. Effect of tissue Doppler on the accuracy of novice and expert interpreters of dobutamine echocardiography. Am J Cardiol 88 (2001) 400-405
71. Pislaru R., Bruce P., Anagnostopoulos L., Allen J., Seward C., Pellikka J., et al. Ultrasound strain imaging of altered myocardial stiffness: stunned versus infarcted reperfused myocardium. Circulation 109 (2004) 2905-2910
72. Abraham T., Belohlavek M., Thomson H., Pislaru C., Khandheria B., Randolph G., et al. Time to onset of regional relaxation: feasibility, variability and utility of a novel index of regional myocardial function by strain rate imaging. J Am Coll Cardiol 39 (2002) 1531-1537
73. Voigt J., Nixdorff U., Bogdan R., Exner B., Schmiedehausen K., Platsch G., et al. Comparison of deformation imaging and velocity imaging for detecting regional inducible ischemia during dobutamine stress echocardiography. Eur Heart J 25 (2004) 1517-1525
74. Merli E., and Sutherland G. Can we quantify ischemia during dobutamine stress echocardiography in clinical practice?. Eur Heart J 25 (2004) 1477-1479
75. Yip G., Khandheria B., and Belohlavek M. Strain echocardiography tracks dobutamine-induced decrease in regional myocardial perfusion in nonocclusive coronary stenosis. J Am Coll Cardiol 44 (2004) 1664-1671
76. Marwick T. Measurement of strain and strain rate by echocardiography: ready for prime time?. J Am Coll Cardiol 47 (2006) 1313-1327
77. Quinones M., Verani M., Haichin R., Mahmarian J., Suarez J., and Zog W. Exercise echocardiography versus 201T1 single-photon emission computed tomography in evaluation of coronary artery disease: analysis of 292 patients. Circulation 85 (1992) 1217-1218
78. Fleischmann K., Hunink M., Kuntz K., and Douglas P. Exercise echocardiography or exercise SPECT imaging?. A meta-analysis of diagnostic test performance. JAMA 280 (1998) 913-920
79. Schinkel A., Bax J., Geleijnse M., Boersma E., Elhendy A., Roelandt J., et al. Noninvasive evaluation of ischemic heart disease: myocardial perfusion imaging or stress echocardiography?. Eur Heart J 24 (2003) 789-800
80. Smart S., Bhatia A., Hellman R., Stoiber T., Krasnow A., and Collier D. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance. J Am Coll Cardiol 36 (2000) 1265-1273
81. Marwick T., D'Hondt A., Baudhuin T., Willemart B., Wijns W., Detry J., et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?. J Am Coll Cardiol 22 (1993) 159-167
82. Roger V.L., Pellikka P.A., Bell M.R., Chow C.W., Bailey K.R., and Seward J.B. Sex and test verification bias: impact on the diagnostic value of exercise echocardiography. [see comments]. Circulation 95 (1997) 405-410
83. McNeill A., Fioretti P., el-Said S., Salustri A., Forster T., and Roelandt J. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 70 (1992) 41-46
84. Schroder K., Voller H., Dingerkus H., Munzberg H., Dissman R., and Linderer T. Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. Am J Cardiol 77 (1996) 909-914
85. Dagianti A., Penco M., Bandiera A., Sgorbini L., and Fedele F. Clinical application of exercise stress echocardiography: supine bicycle or treadmill?. Am J Cardiol 81 (1998) 62-7G
86. Badruddin S., Ahmad A., Mickelson J., et al. Supine bicycle versus post-treadmill exercise echocardiography in the detection of myocardial ischemia: a randomized single-blind crossover trial. J Am Coll Cardiol 33 (1999) 1485-1490
87. Ryan T., Segar D., Sawada S., et al. Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echocardiog 6 (1993) 186-197
88. Hecht H., DeBord L., Shaw R., Dunlap R., Ryan C., Stertzer S., et al. Usefulness of supine bicycle stress echocardiography for detection of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 71 (1993) 293-296
89. Hecht H., DeBord L., Sotomayor N., Shaw R., Dunlap R., and Ryan C. Supine bicycle stress echocardiography: peak exercise imaging is superior to postexercise imaging. J Am Soc Echocardiogr 6 (1993) 265-271
90. Smart S., Knickelbine T., Malik F., and Sagar K. Dobutamine-atropine stress echocardiography for the detection of coronary artery disease in patients with left ventricular hypertrophy: importance of chamber size and systolic wall stress. Circulation 101 (2000) 258-263
91. Yuda S., Khoury V., and Marwick T. Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 40 (2002) 1311-1319
92. Wahi S., and Marwick T. Aortic regurgitation reduces the accuracy of exercise echocardiography for diagnosis of coronary artery disease. J Am Soc Echocardiogr 12 (1999) 967-973
93. Bach D., Muller D., Gros B., and Armstrong W. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 24 (1994) 928-933
94. Ha J., Juracan E., Mahoney D., Oh J., Shub C., Seward J., et al. Hypertensive response to exercise: a potential cause for new wall motion abnormality in the absence of coronary artery disease. J Am Coll Cardiol 39 (2002) 323-327
95. Okeie K., Shimizu M., Yoshio H., Ino H., Yamaguchi M., Matsuyama T., et al. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 36 (2000) 856-863
96. Miller D., Ruddy T., Zusman R., Okada R., Strauss H., and Kanarek D. Left ventricular ejection fraction response during exercise in asymptomatic systemic hypertension. Am J Cardiol 59 (1987) 409-413
97. Schulman D., Tugoen J., Flores A., Dianzumba S., and Reichek N. Left ventricular ejection fraction during supine and upright exercise in patients with systemic hypertension and its relation to peak filling rate. Am J Cardiol 76 (1995) 61-65
98. Melin J., Wijns W., Pouleur H., Robert A., Nannan M., DeCoster P., et al. Ejection fraction response to upright exercise in hypertension: relation to loading conditions and to contractility. Int J Cardiol 17 (1987) 37-49
99. Mottram P., Haluska B., Yuda S., Leano R., and Marwick T. Patients with a hypertensive response to exercise have impaired systolic function without diastolic dysfunction or left ventricular hypertrophy. J Am Coll Cardiol 43 (2004) 848-853
100. Mairesse G., Marwick T., Arnese M., Vanoverschelde J., Cornel J., and Detry J. Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography. Am J Cardiol 76 (1995) 321-325
101. Tandogan I., Yetkin E., Yanik A., Ulusoy F., Temizhan A., and Cehreli S. Comparison of thallium 201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block. Int J Cardiovasc Imaging 17 (2001) 339-345
102. Geleijnse M., Vigna C., Kasprzak J., Rambaldi R., Salvatori M., Elhendy A., et al. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. Eur Heart J 21 (2000) 1666-1673
103. Afridi I., Grayburn P., Panza J., Oh J., and Zoghbi W. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 32 (1998) 921-926
104. Meluzin J., Cerny J., Frelich M., Stetka F., Spinarova L., Popelova J., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction: investigators of this multicenter study. J Am Coll Cardiol 32 (1998) 912-920
105. Naqvi T., Goel R., Forrester J., and Siegel R. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 34 (1999) 1537-1544
106. Eichhorn E., Grayburn P., Mayer S., St John Sutton M., Appleton C., Plehn J., et al. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the beta-blocker evaluation of survival trial (BEST). Circulation 108 (2003) 2336-2341
107. Nagueh S., Mikati I., Weilbaecher D., Reardon M., Al-Zaghrini G., Cacela D., et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 100 (1999) 490-496
108. Elsasser A., Schlepper M., Klovekorn W., Cai W., and Zimmerman R. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 96 (1997) 2920-2931
109. Bito V., Heinzel F., and Weidemann. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res 94 (2004) 794-801
110. Iyer V., and Canty J. Regional desensitization of beta-adrenergic receptor signaling in swine with chronic hibernating myocardium. Circ Res 97 (2005) 789-795
111. Schwarz E., Schoendube F., Schmiedtke S., Schultz G., and Buell U. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 31 (1998) 1018-1026
112. Cwajg J., Cwajg E., Nagueh D., He Z., Qureshi U., and Olmos L. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 35 (2000) 1152-1161
113. Biagini E., Galema T., Schinkel A., Vletter W., Roelandt J., and Ten Cate F. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol 43 (2004) 1489-1493
114. Yong Y., Nagueh S., Shimoni S., Shan K., He Z., and Reardon M. Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization. Circulation 103 (2001) 1232-1237
115. Ling L., Christian T., Mulvagh S., Klarich K., Hauser M., Nishimura R., et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography, nitroglycerin-dobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J 151 (2006) 882-889
116. Senior R., and Lahiri A. Role of dobutamine echocardiography in detection of myocardial viability for predicting outcome after revascularization in ischemic cardiomyopathy. J Am Soc Echocardiogr 14 (2001) 240-248
117. Afridi I., Kleiman N., Raizner A., and Zoghbi W. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91 (1995)
118. Bax J., Poldermans D., and Elhendy A. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 (1999) 163-169
119. Rizzello V., Poldermans D., and Boersma E. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 110 (2004) 2383-2388
120. Hoffmann R., Altiok E., Nowak B., Heussen N., Kuhl H., Kaiser H., et al. Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability in patients with depressed left ventricular function. J Am Coll Cardiol 39 (2002) 443-449
121. Hoffmann R., Altiok E., Nowak B., Kuhl H., Kaiser H., Buell U., et al. Strain rate analysis allows detection of differences in diastolic function between viable and nonviable myocardial segments. J Am Soc Echocardiogr 18 (2005) 330-335
122. Zhang Y., Chan A., Yu C., Yip G., Fung J., Lam W., et al. Strain rate imaging differentiates transmural from non-transmural myocardial infarction: a validation study using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 864-871
123. Bergeron S., Ommen S., Bailey K., Oh J., McCully R., and Pellikka P. Exercise echocardiographic findings and outcome of patients referred for evaluation of dyspnea. J Am Coll Cardiol 43 (2004) 2242-2246
124. Ha J., Lulic F., Bailey K., Pellikka P., Seward J., Tajik A., et al. Effects of treadmill exercise on mitral inflow and annular velocities in healthy adults. Am J Cardiol 91 (2003) 114-115
125. Ha J., Pellikka P., Oh J., Ommen S., Stussy V., Bailey K., et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. J Am Soc Echocardiogr 18 (2005) 63-68
126. Burgess M., Jenkins C., Sharman J., and Marwick T. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol 47 (2006) 1891-1900
127. Galie N., Torbicki A., Barst R., Dartevelle P., Haworth S., Higenbottam T., et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 25 (2004) 2243-2278
128. Himelman R., Stulbarg M., Kircher B., Lee E., Kee L., Dean N., et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 79 (1989) 863-871
129. Nootens M., Wolfkiel C., Chomka E., and Rich S. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol 75 (1995) 374-377
130. Holverda S., Gan C., Marcus J., Postmus P., Boonstra A., and Vonk-Noordegraaf A. Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol 47 (2006) 1732-1733
131. Bossone E., Rubenfire M., Bach D., Ricciardi M., and Armstrong W. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol 33 (1999) 1662-1666
132. Grunig E., Mereles D., Hildebrandt W., Swenson E., Kubler W., Kuecherer H., et al. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 35 (2000) 980-987
133. Wu W., Aziz G., and Sadaniantz A. The use of stress echocardiography in the assessment of mitral valvular disease. Echocardiography 21 (2004) 451-458
134. Bonow R., Carabello B., Chatterjee K., de Leon A., Faxon D., Freed M., et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologist endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48 (2006) e1-e148
135. Voelker W., Jaksch R., Dittman H., Schmitt A., Maiuser M., and Karsch K. Validation of continuous-wave Doppler measurement of mitral valve gradients during exercise: a simultaneous Doppler-catheter study. Eur Heart J 10 (1989) 737-746
136. Aviles R., Nishimura R., Pellikka P., Andreen K., and Holmes D. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valve valvotomy. J Am Soc Echocardiogr 14 (2001) 676-681
137. Hecker S., Zabalgoitia M., Ashline P., Oneschuk L., O'Rourke R., and Herrera C. Comparison of exercise and dobutamine stress echocardiography in assessing mitral stenosis. Am J Cardiol 80 (1997) 1374-1377
138. Mohan J., Patel A., Passey R., Gupta D., Kumar M., Arora R., et al. Is the mitral valve area flow-dependent in mitral stenosis?. A dobutamine stress echocardiographic study. J Am Coll Cardiol 40 (2002) 1809-1815
139. Zoghbi W., Enriquez-Sarano M., Foster E., Grayburn P., Kraft C., Levine R., et al. American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
140. Tischler M., Battle R., Saha M., Niggel J., and LeWinter M. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol 25 (1995) 128-133
141. Pierard L., and Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 (2004) 1627-1634
142. Leung D., Griffin B., Stewart W., Cosgrove D., Thomas J., and Marwick T. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 28 (1996) 1198-1205
143. deFilippi C., Willett D., Brickner M., Appleton C., Yancy C., Eichhorn E., et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75 (1995) 191-194
144. Nishimura R., Grantham J., Connolly H., Schaff H., Higano S., and Holmes D. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106 (2002) 809-813
145. Blais C., Burwash I., Mundigler G., Dumesnil J., Loho N., Rader F., et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (truly or pseudo-severe aortic stenosis) study. Circulation 113 (2006) 711-721
146. Monin J., Quere J., Monchi M., Petit H., Baleynaud S., Chauvel C., et al. Low-gradient aortic stenosis; operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108 (2003) 319-324
147. Zabalgoitia M., Kopec K., Abochamh D., Oneschuk L., Herrera C., and O'Rourke R. Usefulness of dobutamine echocardiography in the hemodynamic assessment of mechanical prostheses in the aortic valve position. Am J Cardiol 80 (1997) 523-526
148. Izzat M., Birdi I., Wilde P., Bryan A., and Angelini G. Evaluation of the hemodynamic performance of small CarboMedics aortic prostheses using dobutamine-stress Doppler echocardiography. Ann Thorac Surg 60 (1995) 104-152
149. Zabalgoitia M., Kopec K., Oneschuk L., Linn W., Herrera C., and O'Rourke R. Use of dobutamine stress echocardiography in assessing mechanical aortic prostheses: comparison with exercise echocardiography. J Heart Valve Dis 6 (1997) 253-257
150. McCully R., Roger V., Mahoney D., Burger K., Click R., Seward J., et al. Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. J Am Coll Cardiol 39 (2002) 1345-1352
151. McCully R., Roger V., Ommen S., Mahoney D., Burger K., Freeman W., et al. Outcomes of patients with reduced exercise capacity at time of exercise echocardiography. Mayo Clin Proc 79 (2004) 750-757
152. Sicari R., Pasanisi E., Venneri L., Landi P., Cortigiani L., and Picano E. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 41 (2003) 589-595
153. Tsutsui J., Elhendy A., Anderson J., Zie F., McGrain A., and Porter T. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 112 (2005) 1440-1450
154. Elhendy A., Modesto K., Mahoney D., Khandheria B., Seward J., and Pellikka P. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 41 (2003) 129-135
155. McCully R., Roger V., Mahoney D., Karon B., Oh J., Miller F.J., et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 31 (1998) 144-149
156. Sawada S., Ryan T., Conley M., and Corya B. Prognostic value of a normal exercise echocardiogram. Am Heart J 120 (1990) 49-55
157. Elhendy A., Mahoney D., McCully R., Seward J., Burger K., and Pellikka P. Use of scoring model combing clinical, exercise test, and echocardiographic data to predict mortality in patients with known or suspected coronary artery disease. Am J Cardiol 93 (2004) 1223-1228
158. Marwick T., Case C., Poldermans D., Boersma E., Bax J., Sawada S., et al. A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms. J Am Coll Cardiol 43 (2004) 2102-2107
159. Marwick T., Case C., Vasey C., Allen S., Short L., and Thomas J. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation 103 (2001) 2566-2571
160. Marwick T., Case C., and Sawada S. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 37 (2001) 754-760
161. Arruda-Olson A., Juracan E., Mahoney D., McCully R., Roger V., and Pellikka P. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference?. J Am Coll Cardiol 39 (2002) 625-631
162. Biagini E., Elhendy A., Bax J., Rizzello V., Schinkel A., van Domburg R., et al. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. J Am Coll Cardiol 45 (2005) 93-97
163. Elhendy A., Arruda A., Mahoney D., and Pellikka P. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 (2001) 1551-1557
164. Elhendy A., Mahoney D., Khandheria B., Paterick T., Burger K., and Pellikka P. Prognostic significance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol 40 (2002) 1623-1629
165. Elhendy A., Cornel J., Roelandt J., van Domburg R., Nierop P., Geleynse M.S., et al. Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol 77 (1996) 955-959
166. Elhendy A., Cornel J., Roelandt J., Van Domburg R., and Fioretti P. Akinesis becoming dyskinesis during dobutamine stress echocardiography: a predictor of poor functional recovery after surgical revascularization. Chest 110 (1996) 155-158
167. Sicari R., Cortigiani L., Bigi R., Landi P., Raciti M., Picano E., et al. Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing. Circulation 109 (2004) 2428-2431
168. Marwick T., Case C., Sawada S., Vasey C., and Thomas J. Prediction of outcomes in hypertensive patients with suspected coronary disease. Hypertension 39 (2002) 1113-1118
169. Cortigiani L., Coletta C., and Bigi R. Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain. Am J Cardiol 91 (2003) 941-945
170. Cortigiani L., Picano E., Vigna C., Lattanzi F., Coletta C., Mariotti E., et al. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block. Am J Med 110 (2001) 361-369
171. Smart S., Dionisopoulos P., and Knickelbine T. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 33 (1999) 512-521
172. Poldermans D., Bax J., Elhendy A., Sozzi F., Boersma E., Thomson I., et al. Long-term prognostic value of dobutamine stress echocardiography in patients with atrial fibrillation. Chest 119 (2001) 144-149
173. Shaw L., Vasey C., Sawada S., Rimmerman C., and Marwick T. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J 26 (2005) 447-456
174. Marwick T., Anderson T., Williams M., Haluska B., Melin J., Pashkow F., et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 26 (1995) 335-341
175. Elhendy A., Geleijnse M., and van Domburg R. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 80 (1997) 1414-1418
176. Smart S., Knickelbine T., Stoiber T., Carlos M., Wynsen J., and Sagar K. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 95 (1997) 1394-1401
177. Desideri A., Fioretti P., Cortigiani L., Trocino G., Astarita C., Gregori D., et al. Pre-discharge stress echocardiography and exercise ECG for risk stratification after uncomplicated acute myocardial infarction: results of the COSTAMI-II (cost of strategies after myocardial infarction) trial. Heart 91 (2005) 146-151
178. Carlos M., Smart S., Wynsen J., and Sagar K. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 95 (1997) 1402-1410
179. Sicari R., Landi P., Picano E., Pirelli S., Chiaranda G., Previtali M., et al. Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction: a prospective international large scale multicenter study. Eur Heart J 23 (2002) 1030-1037
180. Greco C., Salustri A., Seccareccia F., Ciavatti M., Biferali F., Valtorta C., et al. Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise echocardiography. J Am Coll Cardiol 29 (1997) 261-267
181. Ryan T., Armstrong W., O'Donnell J., and Feigenbaum H. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 114 (1987) 1305-1315
182. Williams M., Obadashian J., and Lauer M. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 27 (1996) 132-139
183. Elhendy A., Sozzi F., van Domburg R., Bax J., Schinkel A., Roelandt J., et al. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 96 (2005) 469-473
184. Arruda A., Das F., Roger R., Klarich J., Mahoney A., and Pellikka J. Prognostic value of exercise echocardiography in 2,632 patients ≥ 65 years of age. J Am Coll Cardiol 37 (2001) 1036-1041
185. Biagini E., Elhendy A., Schinkel A., Rizzello V., Bax J., Sozzi F., et al. Long-term prediction of mortality in elderly persons by dobutamine stress echocardiography. J Gerontol A Biol Sci Med Sci 60 (2005) 1333-1338
186. Chaowalit N., Arruda A., McCully R., Bailey K., and Pellikka P. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol 47 (2006) 1029-1036
187. Sozzi F., Elhendy A., and Roelandt J. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 26 (2003) 1074-1078
188. Marwick T., Case C., Sawada S., Vasey C., Short L., and Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25 (2002) 1042-1048
189. Boersma E., Poldermans D., Bax J., Steyerberg E., Thomson I., Banga J., et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. J Am Med Assoc 285 (2001) 1865-1873
190. Shaw L., Eagle K., Gersh B., and Miller D. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 27 (1996) 787-798
191. Sicari R., Ripoli A., Picano E., Djordjevic-Dikic A., Di Giovanbattista R., Minardi G., et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large-scale multicenter study in 509 patients; EPIC (echo Persantine international cooperative) study group. Circulation 100 (1999) 269-274
192. Poldermans D., Fioretti P., Forster T., and Thomson I. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 87 (1993) 1506-1512
193. Poldermans D., Arnese M., Fioretti P., Boersma E., Thomson I., Rambaldi R., et al. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation 95 (1997) 53-58
194. Kertai M., Boersma E., and Bax J. A meta-analysis comparing the prognostic accuracy of six diagnostic rests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89 (2003) 1327-1334
195. Elhendy A., Geleijnse M., Roelandt J., Cornel J., van Domburg R., El-Rafaee M., et al. Assessment of patients after coronary artery bypass grafting by dobutamine stress echocardiography. Am J Cardiol 77 (1996) 1234-1236
196. Kafka H., Leach A., and Fitzgibbon G. Exercise echocardiography after coronary artery bypass surgery: correlation with coronary angiography. J Am Coll Cardiol 25 (1995) 1019-1023
197. Dagianti A., Rosanio S., Penco M., Dagianti A., Sciomer S., Tocchi M., et al. Clinical and prognostic usefulness of supine bicycle exercise echocardiography in the functional evaluation of patients undergoing elective percutaneous transluminal coronary angioplasty. Circulation 95 (1997) 1176-1184
198. Arruda A., McCully R., Oh J., Mahoney D., Seward J., and Pellikka P. Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol 87 (2001) 1069-1073
199. Bountioukos M., Elhendy A., van Domburg R., Schinkel A., Bax J., Krenning B., et al. Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularization. Heart 90 (2004) 1031-1035
200. Elhendy A., Mahoney D., Burger K., McCully R., and Pellikka P. Prognostic value of exercise echocardiography in patients with classic angina pectoris. Am J Cardiol 94 (2004) 559-563
201. Biagini E., Elhendy A., Schinkel A., Bax J., Vittoria R., van Domburg R., et al. Risk stratification of patients with classic angina pectoris and no history of coronary artery disease by dobutamine stress echocardiography. J Am Coll Cardiol 46 (2005) 730-732
202. Klocke F., Baird M., Lorell B., Bateman T., Messer J., Berman D., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 42 (2003) 1318-1333
203. Metz L., Beattie M., Hom R., Redberg R., Grady D., and Fleischmann K. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 49 (2007) 227-237
204. Geleijnse M., Elhendy A., van Domburg R., Cornel J., Rambaldi R., Salustri A., et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain: echocardiography, perfusion scintigraphy, or both?. Circulation 96 (1997) 137-147
205. Olmos L., Dakik H., Gordon R., Dunn J., Verani M., Quinones M., et al. Long-term prognostic value of exercise echocardiography compared with exercise 201TI, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 98 (1998) 2679-2686
206. Schinkel A., Bax J., Elhendy A., van Domburg R., Valkema R., Vourvouri E., et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 117 (2004) 1-9
207. Shaw L., Marwick T., Berman D., Sawada S., Heller G., Vasey C., et al. Incremental cost-effectiveness of exercise echocardiography vs SPECT imaging for evaluation of stable chest pain. Eur Heart J 27 (2006) 2448-2458
208. Ahmad M., Tianrong X., McCulloch M., Abreo G., and Runge M. Real-time three-dimensional dobutamine stress echocardiography in assessment of ischemia: comparison with two-dimensional dobutamine stress echocardiography. J Am Coll Cardiol 37 (2001) 1303-1308
209. Sugeng L., Weinert L., and Lang R. Left ventricular assessment using real-time three dimensional echocardiography. Heart 89 (2003) 29-36
210. Yang H., Pellikka P., McCully R., Oh J., Kukuzke J., Khandheria B., et al. Role of biplane and biplane echocardiographically guided 3-dimensional echocardiography during dobutamine stress echocardiography. J Am Soc Echocardiog 19 (2006) 1136-1143
211. Wei K., Ragosta M., Thorpe J., Coggins M., Moos S., and Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 103 (2001) 2560-2565
212. Masugata H., Lafitte S., Peters B., Strachan G., and DeMaria A. Comparison of real-time and intermittent triggered myocardial contrast echocardiography for quantification of coronary stenosis severity and transmural perfusion gradient. Circulation 104 (2001) 1550-1556
213. Moir S., Haluska B., Jenkins C., Fathi R., and Marwick T. Incremental benefit of myocardial contrast to combine dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 110 (2004) 1108-1113
214. Elhendy A., O'Leary E., Xie F., Mcgrain A., Anderson J., and Porter T. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 44 (2004) 2185-2191